RxDoctor Payments Data

Emil Annabi, MD

Pain Medicine · Tucson, AZNPI 1295997179

Payments from drug & device makers

What this record shows

22 manufacturers reported payments, led by Boston Scientific at 30.1% of the total. Reporting peaked in 2024 at $2,631 and has fallen 58.0% since, to $1,104 in 2025.

$6,151in general payments, 2019–2025

Across 92 payments — averaging $66.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Abbott$1K
  • Stryker$724
  • Surgentec$641
  • Radius Health, Inc.$217
  • SPR Therapeutics, Inc$169
  • plus $1K from 16 others
$4,500in research payments, 2019–2025

Across 1 payment — averaging $4500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$5K

What the payments were for

  • Travel & lodging$2,71144%
  • Food & beverage$3,44056%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,151 in reported general payments places this provider in the 60th percentile of 180 pain medicine providers in Arizona.

See all pain medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$238,201
Medicare patients
672
Services billed
2,438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate20$9,937
Buprenorphine50$8,707
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen108$3,059
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen96$2,756
Oxycodone Hcl112$2,080
Morphine Sulfate ErMorphine Sulfate51$1,373
Tramadol Hcl72$790
Gabapentin74$705
Pregabalin17$393
Morphine Sulfate19$359
Tizanidine Hcl32$345
Baclofen17$328
Hydromorphone Hcl23$277
Methocarbamol13$227
Cyclobenzaprine Hcl13$153

Paid to pharmacies, not to this prescriber.

Other pain medicine in Tucson

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →